Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
about
Hydrogen sulfide and translational medicineRedox regulation of endothelial cell fateCystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistanceVascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide researchInvestigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.PLP-dependent H(2)S biogenesis.Hydrogen sulphide and angiogenesis: mechanisms and applications.Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.Metabolic turnover of hydrogen sulfide.A practical look at the chemistry and biology of hydrogen sulfide.Hydrogen sulfide is a signaling molecule and a cytoprotectant.Hydrogen sulfide in biochemistry and medicine.A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal deathH₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase.Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms.Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspectsThe therapeutic potential of hydrogen sulfide: separating hype from hope.Redox Biology of Hydrogen Sulfide: Implications for Physiology, Pathophysiology, and Pharmacology.Hydrogen sulfide: redox metabolism and signaling.Chemical Biology of H2S Signaling through Persulfidation.Hydrogen sulfide improves postischemic neoangiogenesis in the hind limb of cystathionine-β-synthase mutant mice via PPAR-γ/VEGF axis
P2860
Q26998305-0238C884-70CB-4FCB-96FF-373CF5BF0671Q28392484-89F45323-30DF-488A-9658-AF330931B355Q28535061-BFB9BE1D-238C-46DF-A989-7B370C8E040EQ34502082-A0C7DF93-056D-43A7-B447-362490B25454Q34650997-2F4BC27B-35AF-4AEB-9467-C02AB30B47EBQ35353935-774C6EE8-ACF8-4DFA-BB50-A60DA3F1576CQ35375963-A2B57EC8-2FCA-40FC-9BE6-0A9734573E19Q35850118-EBD6EB57-7A4B-4BD3-85C9-CF9649795F8EQ35895252-38914544-73D1-4559-ACDE-5632F0FB0A7BQ35929034-A78636A3-37F3-4B4F-B570-CF76B3DAA335Q35929049-50E4395D-E631-4B2A-9D61-3D345BA34341Q35929408-390721F0-E8CD-4F99-BE5F-061C86222C3AQ36234796-754C2DD6-2C7D-4340-88EC-B0719382307FQ36895184-3AD35803-48BC-452C-9615-DF3D42D742B9Q37686284-A0FC3359-1726-4DDB-8878-7A0018A0B55EQ37686288-B33A521A-0800-461C-A3D2-50F4B7992EDEQ37872122-981E6E55-9330-4B2D-A424-15C298BBC070Q38116513-1061C61C-EF91-4EF8-834F-ED341E91E1C4Q42764772-2D15537A-E45E-402E-B8CE-58A004F1F11EQ47430972-8FBAA68A-9A39-484D-BC06-5DA936301A91Q58770377-72FDE206-A407-4790-9FC8-385349045653
P2860
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
@en
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
@nl
type
label
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
@en
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
@nl
prefLabel
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
@en
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
@nl
P2860
P1476
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
@en
P2093
Benjamin L Predmore
David J Lefer
P2860
P2888
P304
P356
10.1007/S12265-010-9201-Y
P407
P577
2010-07-14T00:00:00Z